Glucotoxicity and Acute Exercise
- Conditions
- Type 2 DiabetesType 1 Diabetes
- Registration Number
- NCT01771614
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
Experimental hyperglycemia (5 hours) will be induced via a constant- or fluctuating-rate glucose infusion to establish different patterns of glycemia in healthy individuals. The effects of these acute models of hyperglycemia on the adaptations to a single aerobic exercise bout will be tested. Changes in pancreatic endocrine function, insulin sensitivity, endothelial function, and oxidative stress will be measured.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Male
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Pancreatic endocrine function 0, 6, 7, 9, and 24 hours The plasma insulin, C-peptide, and glucagon responses to a 0.33 g/kg intravenous glucose tolerance test (IVGTT) will be measured. In each trial, the IVGTT will be performed at T = 0, 6, 7, 9, and 24 hours.
- Secondary Outcome Measures
Name Time Method Oxidative stress 24 hours Urine will be collected over the whole 24-hour period of each trial and 8-iso Prostaglandin F3α will be measured.
Endothelial function 0, 6, 7, 9, and 24 hours Blood flow and flow-mediated dilation by Doppler ultrasound will be measured in each trial at T = 0, 6, 7, 9, and 24 hours.
Glucose tolerance 0, 6, 7, 9, and 24 hours Glucose tolerance will be measured during an IVGTT in each trial at T = 0, 6, 7, 9, and 24 hours.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Birmingham
🇬🇧Birmingham, West Midlands, United Kingdom
University of Birmingham🇬🇧Birmingham, West Midlands, United Kingdom